CLINICAL_TRIALS
trial_result
· 2011-02-01
Clinical Trial Update: Withdrawal of Etanercept After Successful Treatment of Juvenile Idiopathic Arthritis [Phase 4]
Summary
Phase 4 clinical trial investigating withdrawal of etanercept after achieving disease control in Juvenile Idiopathic Arthritis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Erasmus Medical Center | Conditions: Juvenile Idiopathic Arthritis | Phase 4 | Status: UNKNOWN